Treatment with vigabatrin carries the risk of permanent vision loss. The Food and Drug Administration (FDA) has expanded the approval of Sabril® (vigabatrin; Lundbeck) to include treatment of ...

Like Sabril, Vigadrone carries a Boxed Warning regarding the risk of permanent vision loss and is only available to healthcare professionals and patients under a special program called the Vigabatrin ...

Considering taking supplements to treat Complex partial seizures? Below is a list of common natural remedies used to treat or reduce the symptoms of Complex partial seizures. Follow the links to read ...

Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...

According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...

Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic name perampanel) for use in the adjunctive treatment of partial-onset seizures (with or ...

A seizure is a sudden change in the brain's normal electrical activity. During a seizure, brain cells "fire" uncontrollably at up to four times their normal rate, temporarily affecting the way a ...

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...

Share on Pinterest A new drug reduced seizures in subjects with treatment resistant epilepsy in a recent clinical trial. The Good Brigade/Getty Images Researchers say a new medication may potentially ...

Epilepsy surgery has been shown to be an effective treatment for patients with intractable epilepsy. The only randomized controlled trial conducted in this setting to date found a dramatic advantage ...